FP
MD icon

Foundry Partners’s Pediatrix Medical MD Stock Holding History

Foundry Partners’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-208,734
Closed -$3.1M – 339
2022
Q4 		$3.1M Buy
208,734
+42,386
+25% +$692K 0.17% 164
2022
Q3 		$2.75M Buy
166,348
+19,278
+13% +$388K 0.17% 165
2022
Q2 		$3.09M Buy
147,070
+2,482
+2% +$50.7K 0.19% 150
2022
Q1 		$3.4M Sell
144,588
-315,815
-69% -$7.73M 0.17% 168
2021
Q4 		$12.5M Buy
460,403
+66,916
+17% +$1.79M 0.44% 89
2021
Q3 		$11.2M Sell
393,487
-18,769
-5% -$572K 0.4% 95
2021
Q2 		$12.4M Buy
+412,256
New +$12.2M 0.43% 93

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Foundry Partners's MD Position: Q1 2023 in Review

Foundry Partners sold out of Pediatrix Medical (MD) in Q1 2023, closing a stake of 208,734 shares — an estimated $3.1M sold.

Foundry Partners first reported a position in MD in Q2 2021 and held it in 7 quarters. The position peaked at $12.5M in Q4 2021. 214 funds tracked by Wall St. Rank hold MD as of Q1 2023.

  • Foundry Partners reported no remaining Pediatrix Medical position as of Q1 2023 after selling out during the quarter.
  • Foundry Partners sold 208,734 Pediatrix Medical shares in Q1 2023, an estimated $3.1M.
  • Foundry Partners first reported a position in Pediatrix Medical in Q2 2021 and held it in 7 quarters.
  • Foundry Partners's Pediatrix Medical position peaked at $12.5M in Q4 2021.
  • 214 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2023.

Based on Foundry Partners's 13F filing for Q1 2023, filed 3 May 2023.